/
OPHLF
$13.50-$1.05 (-7.22%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$10.06 – $18.67
40% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-11.12
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $288.63B | $292.42B | $309.28B | $361.36B | $447.19B | $502.67B | $486.87B | $519.03B |
| Cost of revenue | $83.83B | $79.06B | $85.57B | $93.51B | $110.06B | $127.13B | $147.95B | $142.61B |
| Gross profit | $204.81B | $213.36B | $223.71B | $267.85B | $337.13B | $375.55B | $338.92B | $376.42B |
| Gross margin | 71.0% | 73.0% | 72.3% | 74.1% | 75.4% | 74.7% | 69.6% | 72.5% |
| R&D | $70.01B | $66.50B | $62.38B | $75.88B | $95.34B | $112.38B | $149.87B | $147.97B |
| Operating income | $62.01B | $77.49B | $92.10B | $114.91B | $152.29B | $163.10B | $59.75B | $103.99B |
| EBITDA | $74.20B | $91.92B | $116.85B | $128.54B | $167.50B | $178.44B | $91.54B | $141.98B |
| Net income | $51.54B | $59.70B | $75.42B | $80.52B | $112.72B | $127.98B | $50.05B | $70.21B |
| Net margin | 17.9% | 20.4% | 24.4% | 22.3% | 25.2% | 25.5% | 10.3% | 13.5% |
| EPS (diluted) | 100.24 | 118.45 | 151.09 | 162.16 | 230.79 | 266.60 | 106.41 | 148.60 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $453.1B | $148.60 | $144.03–$156.12 | 1 |
| 2028 | $443.9B | $133.02 | $128.93–$139.76 | 1 |
| 2029 | $457.5B | $140.07 | $135.76–$147.15 | 1 |
| 2030 | $487.4B | $155.98 | $151.18–$163.87 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$65.92
Price
$13.50
Implied upside
+388%
Peer comparison
ONO PHARMACEUTICAL
ONO PHARMACEUTICAL
Held by traders on TradeandTell
No one on the platform currently holds OPHLF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in OPHLF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1185.19% ($160.00/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $40.0000 | |
| 2026-09-30 | $40.0000 | |
| 2026-03-31 | $40.0000 | 2026-06-19 |
| 2025-09-30 | $40.0000 | 2025-12-01 |
| 2025-03-31 | $40.0000 | 2025-06-20 |
| 2024-09-30 | $40.0000 | 2024-12-02 |
| 2024-03-28 | $40.0000 | 2024-06-21 |
| 2023-09-29 | $40.0000 | 2023-12-01 |
Recent trades on TradeandTell
No one on the platform has traded OPHLF yet.